Back

Ophthalmic acid is a bloodborne metabolite that contributes to age-induced cardiomyocyte hypertrophy

Mehdipour, M.; Park, S.; Wei, W.; Long, J. Z.; Huang, G. N.

2024-08-09 physiology
10.1101/2024.08.08.607218 bioRxiv
Show abstract

Cardiac aging involves the development of left ventricular hypertrophy alongside a decline in functional capacity. Here, we use neutral blood exchange to demonstrate that the acute removal of age-accumulated blood factors significantly regresses cardiac hypertrophy in aged mice. The reversal of hypertrophy was not attributed to age-associated hemodynamic effects, implicating a role of blood-derived factors. In addition, the overarching paradigm of systemic aging maintains that the age-related overabundance of plasma proteins are largely responsible for causing pathological phenotypes in tissues. Our results suggest that blood metabolites, not proteins, drive cardiac hypertrophy instead. Upon analyzing serum metabolomics data sets, we identified ophthalmic acid as a circulating metabolite whose levels increase with advanced age. Treatment of adult mouse and neonatal rat cardiomyocytes in culture with ophthalmic acid increased their relative surface areas. This study uncovers a non-protein metabolite that may contribute to cardiomyocyte hypertrophy during aging. Identifying a method to counteract ophthalmic acids hypertrophic effects may reveal novel therapeutic opportunities for cardiac rejuvenation.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Aging Cell
○ 165 papers in training set
Top 0.2%
15.9%
Similar papers in this journal
2
American Journal of Physiology-Heart and Circulatory Physiology
● 36 papers in training set
Top 0.1%
13.5%
Similar papers in this journal
3
GeroScience
○ 109 papers in training set
Top 0.1%
13.2%
Similar papers in this journal
4
Aging
○ 75 papers in training set
Top 0.3%
4.7%
Similar papers in this journal
5
The Journals of Gerontology: Series A
◐ 29 papers in training set
Top 0.1%
4.5%
Similar papers in this journal
50% of probability mass above
6
Scientific Reports
○ 3612 papers in training set
Top 29%
3.4%
7
eLife
● 5828 papers in training set
Top 38%
2.9%
8
Journal of the American Heart Association
○ 140 papers in training set
Top 2%
2.5%
9
Circulation Research
○ 47 papers in training set
Top 0.7%
2.0%
10
Frontiers in Aging
○ 11 papers in training set
Top 0.1%
1.8%
11
Circulation
○ 74 papers in training set
Top 1%
1.8%
12
Cardiovascular Research
◐ 37 papers in training set
Top 0.6%
1.8%
13
npj Aging
○ 22 papers in training set
Top 0.2%
1.8%
14
Nature Aging
○ 60 papers in training set
Top 1%
1.4%
15
iScience
○ 1154 papers in training set
Top 24%
1.2%
16
Journal of Molecular and Cellular Cardiology
○ 40 papers in training set
Top 0.5%
1.2%
17
JACC: Basic to Translational Science
○ 21 papers in training set
Top 0.5%
1.2%
18
Circulation: Heart Failure
○ 14 papers in training set
Top 0.5%
1.1%
19
Communications Biology
○ 993 papers in training set
Top 24%
1.1%
20
The Journal of Physiology
○ 150 papers in training set
Top 2%
1.1%
21
European Heart Journal
◐ 22 papers in training set
Top 0.9%
1.0%
22
Frontiers in Physiology
○ 106 papers in training set
Top 2%
0.9%
23
Circulation: Genomic and Precision Medicine
○ 48 papers in training set
Top 0.8%
0.9%
24
Nature Communications
○ 5641 papers in training set
Top 54%
0.9%
25
Stem Cells
◐ 31 papers in training set
Top 0.6%
0.9%
26
FASEB BioAdvances
○ 18 papers in training set
Top 0.3%
0.9%
27
eBioMedicine
○ 183 papers in training set
Top 7%
0.6%
28
Disease Models & Mechanisms
139 papers in training set
Top 3%
0.6%
29
The American Journal of Pathology
○ 32 papers in training set
Top 1%
0.5%
30
Cells
○ 249 papers in training set
Top 9%
0.5%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.